The first clinical application of nitrous oxide (N2O) was in 1844, by an American dentist named Horace Wells who used it to control pain during tooth extraction. Since then, N2O has shared a 170-year history with modern dental anesthesia. N2O, an odorless and colorless gas, is very appealing as a sedative owing to its anxiolytic, analgesic, and amnestic properties, rapid onset and recovery, and, in particular, needle-free application. Numerous studies have reported that N2O can be used safely and effectively as a procedural sedation and analgesia (PSA) agent. However, N2O can lead to the irreversible inactivation of vitamin B12, which is essential for humans; although rare, this can be fatal in some patients.
INTRODUCTION
Many patients experience dental fear and anxiety (DFA), which imposes a significant level of stress in dentists who must treat such patients [1] [2] [3] . While there are various non-pharmacological methods for dealing with DFA, these methods may not be effective in patients with severe DFA; therefore, pharmacological approaches including sedation and general anesthesia (GA) may be unavoidable in treating some patients [4] . Although there is very little difference in the prevalence of DFA between adults and children [1, 2] , adults are able to avoid their DFA by canceling or delaying their own dental appointments, whereas children often do not have such options.
Moreover, children are often unable to repress their expression of fear, which may manifest as excessive crying and/or physical struggle. These reasons led to the early adoption of sedation in pediatric dentistry. According to a survey of the members of International
Association of Paediatric Dentistry (IAPD) and European
Academy of Paediatric Dentistry (EAPD), the pharmacological method most often used for behavioral control was GA (52%), followed by N 2 O-only sedation (46%) and oral sedation (44%) [5] . The objective of this review was to investigate the properties of N 2 O as a PSA agent and identify the adverse events (AEs) associated with N2O.
N 2 O FOR PROCEDURAL SEDATION AND ANALGESIA
Since its initial introduction in 1844 by an American dentist named Horace Wells for pain control during tooth extraction, N2O has been widely used in dentistry to control the pain and distress in patients [6] . N 2 O is an odorless and colorless gas with anxiolytic, analgesic, and amnestic properties, along with rapid onset and recovery, which represent the ideal characteristics of a sedative [6, 7] .
Moreover, as a major advantage of using N 2 O is the mitigation of needle phobia [7] , it is therefore commonly to achieve PSA in pediatric patients. In particular, N 2 O is used for simple venipuncture [8] , with Pasarón and colleagues [9] reporting that 98% of patients who under- [24] reported that three out of six atypical AEs were associated with apnea/O 2 desaturation after recovery under room air when patients were supplied with 100%
O2 for 2-3 minutes after cessation of N2O. Meanwhile, Malamed [22] reported that 100% O 2 should be supplied for at least 3-5 minutes for the complete elimination of N2O from the body, after which the patient should be re-evaluated to determine whether additional 100% O 2 should be supplied.
The most common AE associated with using PSA with N 2 O is vomiting [9, 12, 13, 24] . Burnweit et al. [25] reported that preoperative fasting is a cause of nausea and vomiting. In a retrospective review of 12 years of cases from a single institution, the rate of vomiting among patients who were asked to eat something light during 2 hours before the procedure was 0.7%, which was lower than the vomiting rates found in other studies ( [9] . In the study by Babl et al. [13] , which required at supply [12] .
Recently, laryngospasm was reported after PSA with only N2O/O2 [26] . [29] , an essential nutrient that acts as a cofactor in the folate and methionine cycles in humans [30] . However, because the human body is unable to synthesize vitamin B 12 , it must be obtained through the consumption of foods of animal origin [31] . However, when vitamin B 12 deficiency is subclinical, such patients may appear to be healthy and consequently classified as ASA class I without any suspicion; indeed, they may even have a previous history of uneventful N 2 O anesthesia or sedation [40] . Caution should be taken as the use of N2O on such patients may result in fatal outcomes [40] .
The first case of hematological changes as a result of prolonged N2O use was a report by Goilmsen in 1955 [41] . At the time of the report, prolonged N 2 O use was not identified as the cause; this was subsequently determined by Lassen et al. in 1956 [42] . In this study, [37, 40] .
Previously, reports on N2O toxicity have been related to GA, recreational abuse, and occupational exposure [49] [50] [51] [52] [53] . However, the important factor was not whether Although there are differences in prevalence based on ethnicity, the number of patients with risk factors for N2O toxicity is a low proportion of the total population [61] . 
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